Our Executive Board
John Doidge joined GMG in January 2017 as the Non-executive Chairman of the Group. John’s focus is to support the Board of Directors with the Group’s strategy, oversee the development of Corporate Fiducidary services and ensure synergies among the new business divisions of the Group.
Chief Executive Officer
Dave Elzas co-founded GMG in 2000 and is the Group Managing Director and CEO. Dave’s main focus is overseeing the implementation of the Group’s strategy and serving a portfolio of institutional clients. Dave also plays a key role in the firm’s real estate transactions and joint ventures.
CEO, Real Estate
Newman Leech co-founded GMG in 2000 and is CEO, Real Estate. Newman manages GMG’s proprietary real estate transactions and serves a portfolio of high net worth clients.
Managing Director, Wealth Planning
Haggay Aidlin joined GMG in April 2003 as Client Manager. Haggay is Group Managing Director with focus on Corporate Services. He is also the Managing Director of Geneva Management Group (Switzerland) S.A., in addition to managing a portfolio of key clients.
Chief Financial Officer
Henk Barnhoorn joined GMG in March 2008. He is the Group’s CFO and the Managing Director of the Mauritian office. In addition to the overall financial, regulatory and statutory responsibilities Henk serves on the Board of key client companies.
Chief Business Development Officer
Sean Gaskell joined GMG in 2008. He has played an instrumental role in building the GMG business in Africa. Sean is a member of the Group’s investment committees, which review private equity and property investments for GMG’s proprietary transactions. Sean originates private equity transactions and raises capital for the Group’s projects.
Chief Operating Officer
Marco Rapaglia joined GMG as the Group’s COO in April 2014. He is responsible for operations across all of GMG’s offices. Marco oversees client administration teams, drives performance improvement across the business and also serves as a fiduciary director across a number of GMG client companies.